SECURITY ATLAS / EVALUATION BRIEF Veracode ARM platform Research reviewed: 2026-10-18 https://atlasofsecurity.com/landscape/vendors/veracode/ THE ATLAS TAKE Veracode supports application-security testing through several workflows, including pipeline static analysis and platform-managed scans. The distinction matters: documentation states that Pipeline Scan does not share all platform finding-lifecycle features, such as flaw matching and mitigations. Atlas analysis: it can fit a program that wants both developer feedback and governed application assessment, but the two paths need deliberate coordination. Evaluate packaging, baseline behavior, and how a result becomes an owned release decision. Do not assume that a pipeline success updates every centrally tracked application finding. SCOPE Binary-only analysis, pipeline-scan latency, and a cloud-only constraint versus regulated on-premises needs are the main boundary tests. Dynamic testing belongs on non-production sites. Package-firewall and Risk Manager modules should be confirmed as entitled rather than assumed from the platform name. WORTH A LOOK WHEN Teams combining developer pipeline feedback with centrally governed application-security assessment. THINK TWICE WHEN The requirement is a fully local static engine or identical finding lifecycle across every scan mode. IMPLEMENTATION 1. Choose an authoritative workflow Document which results control release approval and which serve early developer feedback. 2. Verify artifact packaging Include representative languages, generated files, and build outputs from the actual pipeline. 3. Reconcile finding states Test known findings, new findings, and accepted-risk decisions across the chosen scan paths. OPERATING REALITY Application packaging, API identities, policy baselines, and result reconciliation require recurring work. Atlas analysis: decide which workflow is authoritative for release approval and audit history. Developers should know whether a pipeline finding is new, accepted elsewhere, or absent because a different artifact or baseline was scanned. COMMERCIAL CONSIDERATIONS Obtain separate confirmation of static, composition, dynamic, and governance entitlements relevant to the application program. - Application and analysis-product scope - Pipeline integration and packaging effort - Governance, sandbox, and support requirements EVALUATION PLAN / PROPOSED TESTS, NOT COMPLETED RESULTS 1. Validate the baseline Acceptance evidence: Run a known finding, create the pipeline baseline, and show a new seeded defect remains actionable. Owner: __________ Pass criterion: __________ Observed result: __________ Evidence location: __________ 2. Compare scan modes Acceptance evidence: Scan the same revision through the chosen modes and explain differences in finding identity and policy. Owner: __________ Pass criterion: __________ Observed result: __________ Evidence location: __________ 3. Prove remediation Acceptance evidence: Retain the code change, regression tests, repeated scan, and the authoritative closed-finding record. Owner: __________ Pass criterion: __________ Observed result: __________ Evidence location: __________ QUESTIONS FOR THE VENDOR - Is binary-only analysis acceptable for the languages and compliance reviewers involved? - What pipeline-scan latency appears on representative changes, and is it usable in the merge window? - Does policy require on-premises analysis that this cloud path cannot satisfy? EVIDENCE GAPS - No independent false-positive, coverage, or scan-performance measurements were produced. - Application packaging and cross-workflow finding behavior need pilot validation. SOURCES Veracode Pipeline Scan (Documentation) https://docs.veracode.com/r/Pipeline_Scan Scan in the Veracode Platform (Documentation) https://docs.veracode.com/r/Scan_source_code_in_the_Veracode_Platform Pipeline Scan API roles (Documentation) https://docs.veracode.com/r/c_pipe_intro Use synthetic fixtures in an authorized environment. Agree rollback and acceptance criteria before enforcement. Documentation research and Atlas analysis. Independent hands-on effectiveness, effort, and complete price remain unassessed.